Dr. Purnendu Chatterjee is the Founder and Chairman of The Chatterjee Group (TCG). Dr. Chatterjee established TCG in 1986 as a global enterprise focusing on technology and knowledge leadership which today has diversified interests in investment banking, real estate, petrochemicals, life sciences and healthcare, hedge fund and wealth management products, outsourcing and technology services including BPO. The Chatterjee Group (TCG) is a private U.S. investment and money management firm, headquartered in New York with over $1 Bn in strategic investments. TCG is one of the largest U.S. foreign direct investors in India and has a sound history of successful investments in technology, telecommunications, real estate and asset creation.
TCG Group of Companies has an Ecosystem model
which contains Technology companies,
reliable Business Processing Outsourcing
companies and world class infrastructure.
The strategic growth areas for The
Chatterjee Group in India include life
sciences, biotechnology, information
technology, hydrocarbons and infrastructure.
Some of the notable initiatives include
Haldia Petrochemicals project, CA TCG
Software (JV with Computer Associates),
SkyTech Solutions (JV with United Airlines),
Bengal Intelligent Park and Asian Gateway.
Some of Chatterjee Group's strategic
investments in the biotechnology sector
include Applied Biosystems, Celera Genomics,
Sepracor, Lynx Therapeutics, Genomics